Publicity and Press Releases. The parties shall mutually agree upon and jointly issue one or more appropriate media/press releases with regard to the existence of this AGREEMENT within seven (7) days of the EFFECTIVE DATE or as soon as reasonably practical thereafter. Neither party shall issue any other press releases relating to this AGREEMENT without prior written approval of the other party; provided however, that:
Appears in 5 contracts
Samples: License Agreement (Genetic Technologies LTD), License Agreement (Genetic Technologies LTD), License Agreement and Release (Genetic Technologies LTD)
Publicity and Press Releases. The parties shall mutually agree upon and jointly issue one or more appropriate media/press releases with regard to the existence of this AGREEMENT within seven (7) days of the EFFECTIVE DATE or as soon as reasonably practical thereafter. Neither party shall issue any other press releases relating to this AGREEMENT without prior written approval of the other party; provided however, that:that each party shall be permitted to post a copy of, provide a link on its web site to or otherwise summarize any permitted disclosures made under this AGREEMENT.
Appears in 1 contract
Samples: Patent License Agreement (Genetic Technologies LTD)
Publicity and Press Releases. The parties shall mutually agree upon and jointly issue one or more appropriate media/press releases with regard to the existence of this AGREEMENT within seven (7) days of the EFFECTIVE DATE or as soon as reasonably practical thereafter. Neither party shall issue any other press releases relating to this AGREEMENT without prior written approval of the other party; provided however, that:.
Appears in 1 contract
Samples: Genetic Technologies LTD
Publicity and Press Releases. The parties shall mutually agree upon and jointly issue issue. Within seven (7) days of the EFFECTIVE DATE or as soon as reasonably practical thereafter, one or more appropriate media/press releases with regard to the existence of this AGREEMENT within seven (7) days and recognizing the LICENSEE as an authorized commercial manufacturer and supplier of oligonucleotides under the EFFECTIVE DATE or as soon as reasonably practical thereafterLICENSED PATENTS. Neither party shall issue any other press releases relating to this AGREEMENT without prior written approval of the other party; provided however, that:
Appears in 1 contract